Dmitry Balyasny’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Dmitry Balyasny's DXCM Position: Q2 2026 in Review
Dmitry Balyasny sold out of DexCom (DXCM) in Q2 2026, closing a stake of 566,312 shares — an estimated $35.6M sold.
Dmitry Balyasny first reported a position in DXCM in Q3 2015 and held it in 29 quarters. The position peaked at $113M in Q4 2022. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Dmitry Balyasny reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
- Dmitry Balyasny sold 566,312 DexCom shares in Q2 2026, an estimated $35.6M.
- Dmitry Balyasny first reported a position in DexCom in Q3 2015 and held it in 29 quarters.
- Dmitry Balyasny's DexCom position peaked at $113M in Q4 2022.
- 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.